Journal
Cancer Discovery
Publication Date
6-2-2023
Volume
13
Issue
6
First Page
1408
Last Page
1427
Document Type
Open Access Publication
DOI
10.1158/2159-8290.CD-22-0939
Rights and Permissions
Waclawiczek A, Leppä AM, Renders S, Stumpf K, Reyneri C, Betz B, Janssen M, Shahswar R, Donato E, Karpova D, Thiel V, Unglaub JM, Grabowski S, Gryzik S, Vierbaum L, Schlenk RF, Röllig C, Hundemer M, Pabst C, Heuser M, Raffel S, Müller-Tidow C, Sauer T, Trumpp A. Combinatorial BCL2 Family Expression in Acute Myeloid Leukemia Stem Cells Predicts Clinical Response to Azacitidine/Venetoclax. Cancer Discov. 2023 Jun 2;13(6):1408-1427. doi: 10.1158/2159-8290. This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license.
Recommended Citation
Waclawiczek, Alexander; Karpova, Darja; and et al., "Combinatorial BCL2 family expression in acute myeloid leukemia stem cells predicts clinical response to azacitidine/venetoclax." Cancer Discovery. 13, 6. 1408 - 1427. (2023).
https://digitalcommons.wustl.edu/oa_4/2085
Additional Links
Supplemental material is available for this article at publisher site.
